Genes & biomarkers

ROS1 fusions

ROS1 · fusion / rearrangement

A gene fusion relevant to treatment in some lung cancers.

Sources checked · Introductory guide

On this page

What does this result mean?

ROS1-positive non-small cell lung cancer has a ROS1-related treatment target. A mention of ROS1 on a report is not by itself a qualifying positive result.[1]

How does it connect to treatment?

In the US, entrectinib is used for adults with ROS1-positive metastatic non-small cell lung cancer. Treatment planning also reviews previous targeted drugs and sites of disease.[1]

What should I check in my report?

Ask whether a fusion/rearrangement was confirmed and by which method. Check whether a VUS or protein-expression result meets the same treatment criteria.

Questions for your care team

  • Does my ROS1 result confirm a treatment-relevant fusion?
  • Which treatments or trials fit my cancer type, stage and previous treatment?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Entrectinib (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

ROS1 fusions | Cancer Encyclopedia | My Chemo Diary